John L Flavin's Net Worth

$1.42 Million

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is John L Flavin?

John L Flavin has an estimated net worth of $1.42 Million. This is based on reported shares across multiple companies, which include Advanced Life Sciences Holdings, Inc., and Pyxis Oncology, Inc..

SEC CIK

John L Flavin's CIK is 0001126556

Past Insider Trading and Trends

2008 was John L Flavin's most active year for acquiring shares with 3 total transactions. John L Flavin's most active month to acquire stocks was the month of February. 2021 was John L Flavin's most active year for disposing of shares, totalling 1 transactions. John L Flavin's most active month to dispose stocks was the month of September. 2006 saw John L Flavin paying a total of $127,800.00 for 40,000 shares, this is the most they've acquired in one year. In 2021 John L Flavin cashed out on 15,190 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Advanced Life Sciences Holdings, Inc. No price found

President /Chief Financial Off

John L Flavin owns 9,593,064 units of Common Stock.acquired a total of 1,200 shares in Advanced Life Sciences Holdings, Inc. at a cost of $1,092.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 16
Form 4
—
0
—
—
0
Nov 25
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Nov 11
Form 4
+0.01%
1.2K
$0.91
$1,092.00
9.59M
Feb 27
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Mar 10
Form 3
—
0
—
—
0
No matching records found

Pyxis Oncology, Inc. (PYXS) Snapshot price: $3.45

Investor

John L Flavin owns 413,015 units of Common Stock which is worth $1,424,901.75. From 2021 to 2024 John L Flavin acquired a total of 243,793 shares in Pyxis Oncology, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.32%
35.22K
—
—
413.01K
Mar 26
Form 4
+58.44%
139.35K
—
—
377.8K
Mar 24
Form 4
+38.94%
66.83K
—
—
238.44K
Mar 31
Form 4
+1.41%
2.39K
—
—
171.61K
Oct 13
Form 4
—
0
—
—
0
Oct 7
Form 3
—
0
—
—
0
No matching records found